Caricamento...
Human disease mutations highlight the inhibitory function of TIM-3
A new study identifies loss-of-function mutations in HAVCR2, which encodes TIM-3, in patients with a rare cutaneous T cell lymphoma associated with aberrant immunological activation. These mutations lead to loss of the TIM-3 immunological checkpoint, thus promoting inflammation and malignancy.
Salvato in:
| Pubblicato in: | Nat Genet |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452640/ https://ncbi.nlm.nih.gov/pubmed/30405215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41588-018-0289-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|